VINC — Vincerx Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign
U.S. STOCKS ON THE MOVE-Ralph Lauren, Gold miners, Aditxt
Vincerx Pharma soars on QumulusAI merger deal
Brief: Vincerx Pharma Announces Termination Of Reverse Merger Term Sheet
Brief: Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2)
Brief: Vincerx Pharma Inc Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing
Brief: Vincerx Pharma Announces Reverse Stock Split
Brief: Vincerx Pharma Inc Terminated The Sales Agreement With Leerink Partners
Brief: Vincerx Pharma Files For Offering Of 2.8 Million Common Stock
Brief: Vincerx Pharma To Implement Cost-Controls To Support Advancing Phase 1 Study Of VIP943
Vincerx Pharma Inc reports results for the quarter ended September 30 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Vincerx Reports Positive Initial Clinical Data From Ongoing Vip943 Phase 1 Dose-Escalation Study And Provides Pipeline And Corporate Updates
Vincerx Pharma Inc reports results for the quarter ended in January - Earnings Summary
Vincerx Pharma Inc reports results for the quarter ended in March - Earnings Summary
Vincerx Pharma Inc expected to post a loss of 23 cents a share - Earnings Preview